DIVISLAB Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > divislab

Technical Analysis

Technical Strength: 6.5 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 54.7. According to RSI analysis, divislab is technically strong. 9.0 DIVISLAB RSI Chart
MACD (?) MACD: 10.8 and Signal Line: 14.2. According to MACD analysis, divislab is marginally weak. 3.0 DIVISLAB MACD Chart
Simple Moving Average (?) Price just got above it's 20-day simple moving average which is a positive signal. According to simple moving average analysis, divislab is in a strong uptrend. Major support levels are 1097.733, 1062.018, 806.4447. 9.0 DIVISLAB Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, divislab is in a strong uptrend. Major support levels are 1089.339, 1049.906, 909.5389. 10.0 DIVISLAB Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.566. 5.0 DIVISLAB Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 1081.6631 and 1063.025. Resistance level is 1142.0. 6.5 DIVISLAB Fibonacci Retracement Chart
Average True Range (?) ATR: 33.3 NA DIVISLAB Average True Range Chart
Average Directional Index (?) ADX is 20.2 which means DIVISLAB is in a trading range and there is no trend. NA DIVISLAB Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
January 19, 2018
Open Price 1090.0
High Price 1103.6
Low Price 1082.6
Close Price 1098.3
Absolute Change 7.9
Percentage Change 0.725%
Weekly Change 0.411%
Monthly Change 1.12%
Yearly Change 48.8%
52-week high 1142.0
52-week low 532.65
Corporate Actions
ExDate Purpose
September 15, 2017 AGM/DIV-RS 10/- PER SHARE
August 18, 2016 ANNUAL GENERAL MEETING
March 17, 2016 INT DIV-RS 10 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.569
Confidence in Beta2.15%
Market Capital Rs. 29156.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 41.73
TTM Price-to-Earnings (P/E) Ratio 26.3
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 19 January 2018: Deliverable Quantity:1.07e+05 NA DIVISLAB Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 19 January 2018: Daily Volatility:0.3057 NA DIVISLAB Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 19 January 2018: PCR_OI:0.407 PCR:0.45 NA DIVISLAB PCR Chart
Option Pain (?) 19 January 2018: Max Pain:1100.0 NA DIVISLAB Option Pain Chart
Premium (?) 19 January 2018 Premium: -0.25 Futures OI:2586400.0 NA DIVISLAB Premium Chart
Option_MAX_OI (?) 19 January 2018: Price:1098.3 Put with maximum OI:1040.0 Call with maximum OI:1140.0 NA DIVISLAB Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
January 25, 2018 1098.05 2586400.0 1292.0 1456.0 1098.3
February 22, 2018 1102.95 196000.0 186.0 204.0 1098.3

Announcements

November 01, 2017 DiOutcome of Board Meetingivi's Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on October 31, 2017.
September 26, 2017 DiShareholders meetingivi's Laboratories Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 25, 2017. Further, the company has informed the Exchange regarding voting results.
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 18, 2018 January 27, 2018 ToResultso consider and approve, inter-alia, the un-audited financial results for the quarter and nine months ended December 31, 2017.
October 23, 2017 October 31, 2017 ToResultso consider and approve, inter-alia, the un-audited financial results for the quarter and half-year ended September 30, 2017.
See all Board Meetings

DIVISLAB is part of...

Index Weightage
NFTYMCAP50 NA
CNXPHARMA NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 1065 Rs. 1074 Rs. 1086 Rs. 1095 Rs. 1107 Rs. 1116 Rs. 1128